83 related articles for article (PubMed ID: 18788910)
1. HIV rebound after discontinuation of antiretroviral therapy increases and expands HIV-specific CD8+ responses but has no impact on its functionality.
López M; Rallón N; Soriano V; Rodríguez I; Valencia E; Labarga P; Moreno V; Vispo E; Roncal F; González-Lahoz J; Benito JM
AIDS Res Hum Retroviruses; 2008 Sep; 24(9):1197-201. PubMed ID: 18788910
[TBL] [Abstract][Full Text] [Related]
2. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.
López M; Soriano V; Rallón N; Cascajero A; González-Lahoz J; Benito JM
Eur J Immunol; 2008 Jun; 38(6):1548-58. PubMed ID: 18421792
[TBL] [Abstract][Full Text] [Related]
3. No major differences in the functional profile of HIV Gag and Nef-specific CD8+ responses between long-term nonprogressors and typical progressors.
López M; Soriano V; Lozano S; Ballesteros C; Cascajero A; Rodés B; De La Vega E; González-Lahoz J; Benito JM
AIDS Res Hum Retroviruses; 2008 Sep; 24(9):1185-95. PubMed ID: 18729773
[TBL] [Abstract][Full Text] [Related]
4. Evolution of the functional profile of HIV-specific CD8+ T cells in patients with different progression of HIV infection over 4 years.
Peris-Pertusa A; López M; Rallón NI; Restrepo C; Soriano V; Benito JM
J Acquir Immune Defic Syndr; 2010 Sep; 55(1):29-38. PubMed ID: 20634703
[TBL] [Abstract][Full Text] [Related]
5. The expansion ability but not the quality of HIV-specific CD8(+) T cells is associated with protective human leucocyte antigen class I alleles in long-term non-progressors.
López M; Peris A; Soriano V; Lozano S; Vicario JL; Rallón NI; Restrepo C; Benito JM
Immunology; 2011 Nov; 134(3):305-13. PubMed ID: 21978000
[TBL] [Abstract][Full Text] [Related]
6. An IL-15 dependent CD8 T cell response to selected HIV epitopes is related to viral control in early-treated HIV-infected subjects.
D'Offizi G; Gioia C; Corpolongo A; Martini F; Paganelli R; Volpi I; Sacchi A; Tozzi V; Narciso P; Poccia F
Int J Immunopathol Pharmacol; 2007; 20(3):473-85. PubMed ID: 17880761
[TBL] [Abstract][Full Text] [Related]
7. Polyfunctional analysis of Gag and Nef specific CD8+ T-cell responses in HIV-1 infected Indian individuals.
Mendiratta S; Vajpayee M; Mojumdar K; Chauhan NK; Sreenivas V
Vaccine; 2011 Feb; 29(6):1150-8. PubMed ID: 21172377
[TBL] [Abstract][Full Text] [Related]
8. Antiretroviral therapy-induced dominant interleukin-2 HIV-1 Gag CD4+ T cell response: evidence of functional recovery of HIV-1-specific CD4+ T cells.
Tsalimalma K; Kordossis T; Choremi-Papadopoulou E
Scand J Immunol; 2011 Mar; 73(3):256-65. PubMed ID: 21204901
[TBL] [Abstract][Full Text] [Related]
9. A pilot study to assess inflammatory biomarker changes when raltegravir is added to a virologically suppressive HAART regimen in HIV-1-infected patients with limited immunological responses.
Lichtenstein KA; Armon C; Nagabhushanam V; Efaw BJ; Frazer-Abel A; Hiserote ME; Alam R
Antivir Ther; 2012; 17(7):1301-9. PubMed ID: 22948290
[TBL] [Abstract][Full Text] [Related]
10. Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection.
Betts MR; Ambrozak DR; Douek DC; Bonhoeffer S; Brenchley JM; Casazza JP; Koup RA; Picker LJ
J Virol; 2001 Dec; 75(24):11983-91. PubMed ID: 11711588
[TBL] [Abstract][Full Text] [Related]
11. MVA-nef induces HIV-1-specific polyfunctional and proliferative T-cell responses revealed by the combination of short- and long-term immune assays.
Kutscher S; Allgayer S; Dembek CJ; Bogner JR; Protzer U; Goebel FD; Erfle V; Cosma A
Gene Ther; 2010 Nov; 17(11):1372-83. PubMed ID: 20535218
[TBL] [Abstract][Full Text] [Related]
12. Virological outcome after structured interruption of antiretroviral therapy for human immunodeficiency virus infection is associated with the functional profile of virus-specific CD8+ T cells.
Daucher M; Price DA; Brenchley JM; Lamoreaux L; Metcalf JA; Rehm C; Nies-Kraske E; Urban E; Yoder C; Rock D; Gumkowski J; Betts MR; Dybul MR; Douek DC
J Virol; 2008 Apr; 82(8):4102-14. PubMed ID: 18234797
[TBL] [Abstract][Full Text] [Related]
13. Immunization with an HIV-1 immunogen induces CD4+ and CD8+ HIV-1-specific polyfunctional responses in patients with chronic HIV-1 infection receiving antiretroviral therapy.
Valor L; Navarro J; Carbone J; Rodríguez-Sáinz C; Gil J; López F; Fernández-Cruz E;
Vaccine; 2008 May; 26(22):2738-45. PubMed ID: 18433946
[TBL] [Abstract][Full Text] [Related]
14. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
[TBL] [Abstract][Full Text] [Related]
15. Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.
Chun TW; Justement JS; Moir S; Hallahan CW; Ehler LA; Liu S; McLaughlin M; Dybul M; Mican JM; Fauci AS
Proc Natl Acad Sci U S A; 2001 Jan; 98(1):253-8. PubMed ID: 11136258
[TBL] [Abstract][Full Text] [Related]
16. Immunological and virological effects of structured treatment interruptions following exposure to hydroxyurea plus didanosine.
Benito JM; López M; Ballesteros C; Lozano S; Capa L; Barreiro P; Sempere J; Gonzalez-Lahoz J; Soriano V
AIDS Res Hum Retroviruses; 2006 Aug; 22(8):734-43. PubMed ID: 16910828
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus type I-specific CD8+ T cell subset abnormalities in chronic infection persist through effective antiretroviral therapy.
Pohling J; Zipperlen K; Hollett NA; Gallant ME; Grant MD
BMC Infect Dis; 2010 May; 10():129. PubMed ID: 20500844
[TBL] [Abstract][Full Text] [Related]
18. Immunodominant HIV-specific CD8+ T-cell responses are common to blood and gastrointestinal mucosa, and Gag-specific responses dominate in rectal mucosa of HIV controllers.
Ferre AL; Lemongello D; Hunt PW; Morris MM; Garcia JC; Pollard RB; Yee HF; Martin JN; Deeks SG; Shacklett BL
J Virol; 2010 Oct; 84(19):10354-65. PubMed ID: 20668079
[TBL] [Abstract][Full Text] [Related]
19. Absence of favourable changes in circulating levels of interleukin-16 or beta-chemokine concentration following structured intermittent interruption treatment of chronic human immunodeficiency virus infection.
Montes de Oca Arjona M; Pérez Cano R; Orozco MJ; Martín Aspas A; Guerrero F; Fernández Gutiérrez Del Alamo C; Girón-González JA
Clin Microbiol Infect; 2005 Jan; 11(1):57-62. PubMed ID: 15649305
[TBL] [Abstract][Full Text] [Related]
20. Single-cell level response of HIV-specific and cytomegalovirus-specific CD4 T cells correlate with viral control in chronic HIV-1 subtype A infection.
Eller MA; Eller LA; Ratto-Kim S; Ouma BJ; Lo V; de Souza M; Guwatudde D; Nails B; Michael NL; Wabwire-Mangen F; Robb ML; Marovich MA; Sandberg JK; Currier JR
J Acquir Immune Defic Syndr; 2012 Sep; 61(1):9-18. PubMed ID: 22580564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
